400,000 people per year are victims of arrhythmias and the prevalence is increasing due to aging populations. The management of atrial fibrillation aims to reduce symptoms and prevent severe complications associated with the disease.
Professor Vardas said that the prevention of complications of atrial fibrillation relies on antithrombotic therapy, the control of ventricular rate and adequate therapy of concomitant cardiac diseases. Symptom relief may require additional rhythm control therapy by cardioversion, antiarrythmic drug therapy or by ablation therapy.
Sudden Cardiac Death, the breakdown of electrical disturbances, is mainly caused by ventricular tachyarrhythmias. The challenge here lies with prevention, both primary and secondary. However there are huge discrepancies between countries as shown below for Secondary Prevention:
Professor Vardas recommended the recent 2010 ESC Guidelines on the Management of Atrial Fibrillation.
Professor Vardas is President Elect of the European Society of Cardiology and President of the European Heart Rhythm Association.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved